MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines

Por Lopez, Cecilia M., Yu, Peter Y., Zhang, Xiaoli, Yilmaz, Ayse Selen, London, Cheryl A., Fenger, Joelle M.
Publicado no PLoS One (2018)

Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2

Por Londhe, Priya, Yu, Peter Y., Ijiri, Yuichi, Ladner, Katherine J., Fenger, Joelle M., London, Cheryl, Houghton, Peter J., Guttridge, Denis C.
Publicado no Front Oncol (2018)

Properties of Disorder-Engineered Black Titanium Dioxide Nanoparticles through Hydrogenation

Por Chen, Xiaobo, Liu, Lei, Liu, Zhi, Marcus, Matthew A., Wang, Wei-Cheng, Oyler, Nathan A., Grass, Michael E., Mao, Baohua, Glans, Per-Anders, Yu, Peter Y., Guo, Jinghua, Mao, Samuel S.
Publicado em 2013

A ‘conovenomic’ analysis of the milked venom from the mollusk-hunting cone snail Conus textile – The pharmacological importance of post-translational modifications

Por Bergeron, Zachary L., Chun, Joycelyn B., Baker, Margaret R., Sandall, David W., Peigneur, Steve, Yu, Peter Y.C., Thapa, Parashar, Milisen, Jeffrey W., Tytgat, Jan, Livett, Bruce G., Bingham, Jon-Paul
Publicado no Peptides (2013)

miR-133a function in the pathogenesis of dedifferentiated liposarcoma

Por Yu, Peter Y., Lopez, Gonzalo, Braggio, Danielle, Koller, David, Bill, Kate Lynn J., Prudner, Bethany C., Zewdu, Abbie, Chen, James L., Iwenofu, O. Hans, Lev, Dina, Strohecker, Anne M., Fenger, Joelle M., Pollock, Raphael E., Guttridge, Denis C.
Publicado no Cancer Cell Int (2018)

Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma

Por Yu, Peter Y., Gardner, Heather L., Roberts, Ryan, Cam, Hakan, Hariharan, Seethalakshmi, Ren, Ling, LeBlanc, Amy K., Xiao, Hui, Lin, Jiayuh, Guttridge, Denis C., Mo, Xiaokui, Bennett, Chad E., Coss, Christopher C., Ling, Yonghua, Phelps, Mitch A., Houghton, Peter, London, Cheryl A.
Publicado no PLoS One (2017)